← All decks

Dermatology

Mastocytosis

Built from Dermatology, 5th Edition

The first 25 slides of Mastocytosis
The first 25 slides, exactly as they appear. The full deck has 83 content slides.

What’s inside

10 sections · 83 slides

  1. 01

    Overview

    • What this chapter covers
    • 50-70%
    • Clinical presentations of childhood and adult-onset mastocytosis

    3 slides

  2. 02

    History and Epidemiology

    From the first case report to who develops mastocytosis today

    • What is mastocytosis
    • A short history
    • Who gets mastocytosis, and when
    • Family patterns

    4 slides

  3. 03

    Pathogenesis

    Mast cell biology and the KIT gene changes that drive disease

    • How a mast cell matures
    • KIT and its trigger, stem cell factor
    • KIT mutations drive mastocytosis
    • The same mutation, very different results
    • From mutation to symptoms

    5 slides

  4. 04

    Cutaneous Mastocytosis in Children

    Mastocytomas, maculopapular disease, and diffuse skin involvement

    • Symptoms from mast cell chemicals
    • Mast cell mediators and associated symptoms of mastocytosis
    • Three childhood skin patterns
    • Mastocytomas
    • Mastocytomas in young children
    • Mastocytoma with blistering and erosion
    • Mastocytomas in infants
    • Bullae in a mastocytoma
    • Multiple-lesion (maculopapular) disease in children
    • Maculopapular cutaneous mastocytosis in children
    • Maculopapular cutaneous mastocytosis in children
    • Diffuse cutaneous mastocytosis
    • Diffuse cutaneous mastocytosis and blistering in infants
    • Diffuse cutaneous mastocytosis
    • Diffuse cutaneous mastocytosis with vesicles and erosions
    • Blistering in young children

    16 slides

  5. 05

    Cutaneous Mastocytosis in Adults

    Urticaria pigmentosa, TMEP, and the Darier sign

    • Adult skin disease: "urticaria pigmentosa"
    • Adult maculopapular mastocytosis ("urticaria pigmentosa")
    • Adult maculopapular mastocytosis ("urticaria pigmentosa")
    • Adult maculopapular mastocytosis with a normal serum tryptase level
    • Less common adult patterns
    • Telangiectasia macularis eruptiva perstans (TMEP)
    • Telangiectasia macularis eruptiva perstans
    • The Darier sign
    • Darier sign in mastocytosis
    • Childhood-onset versus adult-onset disease

    10 slides

  6. 06

    Systemic Manifestations

    How mastocytosis can affect bone, marrow, spleen, gut, liver, and brain

    • Bone involvement
    • How mast cells affect bone
    • Bone marrow, spleen, and lymph nodes
    • Gut, liver, and brain effects

    4 slides

  7. 07

    Classification of Mastocytosis

    The WHO scheme, systemic mastocytosis subtypes, and evaluating a new patient

    • The WHO classification, at a glance
    • The WHO classification system
    • WHO 2016 classification of mastocytosis
    • Diagnosing systemic mastocytosis
    • WHO criteria for the diagnosis of systemic mastocytosis (SM) and related B &C findings
    • WHO criteria for the diagnosis of systemic mastocytosis (SM) and related B &C findings (continued)
    • WHO criteria for the diagnosis of systemic mastocytosis (SM) and related B &C findings (continued)
    • Indolent systemic mastocytosis (ISM)
    • Smoldering SM and SM with a blood neoplasm
    • Aggressive SM and mast cell leukemia
    • Survival of patients with systemic mastocytosis
    • Extra gene mutations affect outlook
    • Evaluating a child with skin lesions
    • Evaluation of a patient with cutaneous lesions of mastocytosis
    • Evaluating an adult with skin lesions

    15 slides

  8. 08

    Pathology and Laboratory Findings

    Skin biopsy findings, special stains, and blood tests like tryptase

    • What a skin biopsy shows
    • Special stains to detect dermal mast cells
    • How dense are the mast cells
    • Blood and urine tests (indirect evidence)

    4 slides

  9. 09

    Differential Diagnosis

    Conditions that can look like mastocytosis at different ages

    • Mimics in children
    • Mimics in adults, and mast cell activation syndrome

    2 slides

  10. 10

    Treatment

    Trigger avoidance, symptom control, and drugs that target KIT

    • Avoiding triggers
    • Therapeutic ladder for mastocytosis
    • Therapeutic ladder for mastocytosis (continued)
    • Therapeutic ladder for mastocytosis (continued)
    • Antihistamines: first-line symptom control
    • Cromolyn, phototherapy, and corticosteroids
    • Emergency treatment and omalizumab
    • Tyrosine kinase inhibitors for advanced disease
    • Other advanced therapies
    • Key take-home points
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    20 slides